{"id":"W2334546249","doi":"10.2310/7750.2009.00031","title":"Patterns of Combination Therapy with Alefacept for the Treatment of Psoriasis in Canada in the AWARE Study","year":2009,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Coastal Health Research Institute; Innovaderm (Canada); Probity Medical Research; University of Toronto; Nexus Clinical Research (Canada); University of British Columbia","funders":"LEO Pharma; Galderma; Janssen Biotech; Astellas Pharma; University of British Columbia; University of Alberta; Abbott Canada","keywords":"Medicine; Concomitant; Discontinuation; Psoriasis; Population; Observational study; Dermatology; Combination therapy; Clinical trial; Plaque psoriasis; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167414,0.0004159571,0.0008433399,0.000934804,0.002104935,0.00152732,0.001045189,0.0006002623,0.002162378],"category_scores_gemma":[0.003505422,0.0003997379,0.001236469,0.003899045,0.000492009,0.0003691493,0.0007837225,0.001069638,0.0001625511],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02078406,"about_ca_system_score_gemma":0.05989087,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9734911,"about_ca_topic_score_gemma":0.9855956,"domain_scores_codex":[0.9968916,0.0003178858,0.0002462715,0.0004734737,0.00143113,0.000639641],"domain_scores_gemma":[0.9963084,0.0002077233,0.001056317,0.0001613985,0.001404076,0.000862073],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001590545,0.0003059754,0.9747356,0.0002481189,0.0004837535,0.0002192908,0.0004868983,0.0001340195,0.0006740005,0.0002327332,0.004576619,0.01631239],"study_design_scores_gemma":[0.0003477424,0.0002562092,0.9928454,0.0001115296,0.0004709461,0.0002314408,0.0007717971,0.0002469697,0.0001564465,0.00005495439,0.004465051,0.00004154858],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9696502,0.004978901,0.0002670863,0.001498148,0.00007086328,0.0006805127,0.01504338,0.00002482106,0.007786139],"genre_scores_gemma":[0.9901918,0.002247186,0.0004465781,0.000748936,0.00002903326,0.0001300962,0.004847249,0.00001642281,0.001342617],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02650887,"threshold_uncertainty_score":0.1507996,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02696615080495873,"score_gpt":0.2538744705991516,"score_spread":0.2269083197941928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}